Trials / Completed
CompletedNCT05194306
PERTRIAL - Perla® Preservation Solution
Evaluation of the Safety and Performance of Perla® Preservation Solution for Donor Liver and Kidney for Transplantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Advanced Life Solutions · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Perla® is a Cold Preservation Solution, with purpose to wash out, preserve during transport liver and kidney grafts in optimal conditions from the donor to the recipient. The purpose of the PERTRIAL clinical investigation is to demonstrate the Performance and Safety of Perla® Cold Preservation solution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Perla® Cold Preservation solution | Perla® must be cooled to 2° to 6 °C prior to use. The cold Preservation Solution is used to flush the isolated organ immediately before removal from the donor and/or immediately after removal from the donor. The solution is then left in the organ vasculature during hypothermic storage and transportation. |
Timeline
- Start date
- 2021-12-11
- Primary completion
- 2022-04-30
- Completion
- 2022-04-30
- First posted
- 2022-01-18
- Last updated
- 2023-05-17
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05194306. Inclusion in this directory is not an endorsement.